Eliyahu Sharon Kalif, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 111,500 shares at $16.21 ($1.8M) on 2025-02-28, disclosed to the SEC on 2025-03-04.
Scheduled sale ($1.8M) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.21 | 55,750 | $904K | 50.0% |
| 2 | $16.21 | 55,750 | $904K | 50.0% |
| Total | $16.21 avg | 111,500 | $1.8M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-02 | $11.6M | — | Filing → |
| TEVA | SELL | 2025-06-16 | $1.9M | — | Filing → |
| TEVA | SELL | 2024-03-07 | $1.0M | — | Filing → |